Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures

[1]  M. Mizuguchi,et al.  Acute encephalopathy associated with influenza and other viral infections , 2007, Acta neurologica Scandinavica. Supplementum.

[2]  S. Fujimoto,et al.  Diffusion MRI abnormalities after prolonged febrile seizures with encephalopathy , 2006, Neurology.

[3]  Henry Ma,et al.  Ischemic Thresholds for Gray and White Matter: A Diffusion and Perfusion Magnetic Resonance Study , 2006, Stroke.

[4]  M. Mizuguchi,et al.  Acute infantile encephalopathy predominantly affecting the frontal lobes. , 2006, Pediatric neurology.

[5]  Richard Frayne,et al.  MR Perfusion and Diffusion in Acute Ischemic Stroke: Human Gray and White Matter have Different Thresholds for Infarction , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  H. Okano,et al.  Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons , 2005, Journal of neurochemistry.

[7]  T. Morishima,et al.  Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. , 2004, Cytokine.

[8]  S. Rose-John,et al.  The effect of gp130 stimulation on glutamate-induced excitotoxicity in primary hippocampal neurons. , 2002, Biochemical and biophysical research communications.

[9]  F. Licastro,et al.  Effects of IL6 and IL1β on aFGF expression and excitotoxicity in NT2N cells , 2002, Journal of Neuroimmunology.

[10]  B. Meldrum,et al.  Concept of activity-induced cell death in epilepsy: historical and contemporary perspectives. , 2002, Progress in brain research.

[11]  R. Seeger,et al.  Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells1 , 2001, The Journal of Immunology.

[12]  F. Graziano,et al.  Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. , 2001, Journal of immunological methods.

[13]  E. Mackenzie,et al.  Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  J. Ahnn,et al.  Analysis of the , 2000 .

[15]  S. Rogers,et al.  Inflammatory Cytokines IL-1α, IL-1β, IL-6, and TNF-α Impart Neuroprotection to an Excitotoxin Through Distinct Pathways , 1999, The Journal of Immunology.

[16]  Chen,et al.  Simultaneous Quantification of Six Human Cytokines in a Single Sample Using Microparticle-based Flow Cytometric Technology. , 1999, Clinical chemistry.

[17]  F. Eckenstein,et al.  Time course of IL-6 expression in experimental CNS ischemia. , 1999, Neurological research.

[18]  T. Ichiyama,et al.  Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/encephalopathy. , 1998, Neurology.

[19]  N. Rothwell,et al.  Cerebral Interleukin-6 is Neuroprotective during Permanent Focal Cerebral Ischemia in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  K. Olsen,et al.  The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis. , 1997, The Journal of infectious diseases.

[21]  N. Rothwell,et al.  Interleukins and cerebral ischaemia. , 1997, International review of neurobiology.

[22]  Y. Itoyama,et al.  Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. , 1995, Stroke.

[23]  M. Howard,et al.  Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.

[24]  E. Lothman.  The biochemical basis and pathophysiology of status epilepticus , 1990, Neurology.

[25]  D. Wallach,et al.  Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. , 1990, The Journal of biological chemistry.

[26]  M. Brenner,et al.  Is circulating tumor necrosis factor bioactive? , 1988, The New England journal of medicine.

[27]  J. Dayer,et al.  A human inhibitor of tumor necrosis factor alpha , 1988, The Journal of experimental medicine.

[28]  B. Meldrum,et al.  Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. , 1973, Archives of neurology.

[29]  B. Meldrum,et al.  Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. , 1973, Archives of neurology.

[30]  H. Gastaut,et al.  H. H. E. Syndrome Hemiconvulsions, Hemiplegia, Epilepsy , 1959, Epilepsia.